IP Library Granted Patent US 12,648,355
Granted Patent B2
US 12,648,355 · App. 18/805,886 · Granted Jun 2, 2026

Light-emitting element, compound, organic compound, display module, lighting module, light-emitting device, display device, lighting device, and electronic device

Inventors: Hideko Inoue (Atsugi, JP); Miki Kanamoto (Atsugi, JP); Hiromi Seo (Sagamihara, JP); Satoshi Seo (Sagamihara, JP); Tatsuyoshi Takahashi (Atsugi, JP); Tomoka Nakagawa (Atsugi, JP)
Assignee: Semiconductor Energy Laboratory Co., Ltd.
H10K85/6576C07D491/048H10K85/615H10K85/657H10K85/6572H10K85/6574H10K50/11H10K85/342H10K85/631H10K2101/10H10K2101/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,648,355
App. No.
18/805,886
Granted
Jun 2, 2026
Kind
B2
Abstract

Alight-emitting element having high emission efficiency is provided. A light-emitting element having a low driving voltage is provided. A novel compound which can be used for a transport layer or as a host material or a light-emitting material of a light-emitting element is provided. A novel compound with a benzofuropyrimidine skeleton is provided. Also provided is a light-emitting element which includes the compound with the benzofuropyrimidine skeleton between a pair of electrodes.

Claims (48)

1 . A mixed material for a light-emitting element comprising:

a first compound comprising a benzofuropyrimidine skeleton; and

a second compound comprising a carbazolyl group,

wherein the first compound and the second compound form an exciplex in a light-emitting layer of the light-emitting element.

2 . A mixed material for a light-emitting element comprising:

a first compound comprising a benzofuropyrimidine skeleton and a dibenzothiophenyl group, a dibenzofuranyl group, or a carbazolyl group; and

a second compound comprising a carbazolyl group,

wherein the dibenzothiophenyl group, the dibenzofuranyl group, or the carbazolyl group is bonded to a pyrimidine skeleton side of the benzofuropyrimidine skeleton.

3 . A light-emitting device comprising:

a pair of electrodes; and

a light-emitting layer between the pair of electrodes,

wherein the light-emitting layer comprises:

a light-emitting substance;

a first compound comprising a benzofuropyrimidine skeleton and a dibenzothiophenyl group, a dibenzofuranyl group, or a carbazolyl group; and

a second compound comprising a carbazolyl group, and

wherein the dibenzothiophenyl group, the dibenzofuranyl group, or the carbazolyl group is bonded to a pyrimidine skeleton side of the benzofuropyrimidine skeleton.

4 . The mixed material for the light-emitting element according to claim 1 ,

wherein the first compound further comprises a dibenzothiophenyl group, a dibenzofuranyl group, or a carbazolyl group, and

wherein the dibenzothiophenyl group, the dibenzofuranyl group, or the carbazolyl group is bonded to a pyrimidine skeleton side of the benzofuropyrimidine skeleton.

5 . The light-emitting device according to claim 3 , wherein the first compound and the second compound form an exciplex.

6 . The mixed material for the light-emitting element according to claim 4 ,

wherein the first compound is represented by formula (G1):

wherein A 1 represents a group having 6 to 100 carbon atoms, the group comprising the dibenzothiophenyl group, the dibenzofuranyl group, or the carbazolyl group, and

wherein R 1 to R 5 separately represent any one of hydrogen, an alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted monocyclic saturated hydrocarbon having 5 to 7 carbon atoms, a substituted or unsubstituted polycyclic saturated hydrocarbon having 7 to 10 carbon atoms, and a substituted or unsubstituted aryl group having 6 to 13 carbon atoms.

7 . The mixed material for the light-emitting element according to claim 2 ,

wherein the first compound is represented by formula (G1):

wherein A 1 represents a group having 6 to 100 carbon atoms, the group comprising the dibenzothiophenyl group, the dibenzofuranyl group, or the carbazolyl group, and

wherein R 1 to R 5 separately represent any one of hydrogen, an alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted monocyclic saturated hydrocarbon having 5 to 7 carbon atoms, a substituted or unsubstituted polycyclic saturated hydrocarbon having 7 to 10 carbon atoms, and a substituted or unsubstituted aryl group having 6 to 13 carbon atoms.

8 . The light-emitting device according to claim 3 ,

wherein the first compound is represented by formula (G1):

wherein A 1 represents a group having 6 to 100 carbon atoms, the group comprising the dibenzothiophenyl group, the dibenzofuranyl group, or the carbazolyl group, and

wherein R 1 to R 5 separately represent any one of hydrogen, an alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted monocyclic saturated hydrocarbon having 5 to 7 carbon atoms, a substituted or unsubstituted polycyclic saturated hydrocarbon having 7 to 10 carbon atoms, and a substituted or unsubstituted aryl group having 6 to 13 carbon atoms.

9 . The mixed material for the light-emitting element according to claim 4 ,

wherein the first compound further comprises a phenylene group on the pyrimidine skeleton side of the benzofuropyrimidine skeleton.

10 . The mixed material for the light-emitting element according to claim 2 ,

wherein the first compound further comprises a phenylene group on the pyrimidine skeleton side of the benzofuropyrimidine skeleton.

11 . The light-emitting device according to claim 3 ,

wherein the first compound further comprises a phenylene group on the pyrimidine skeleton side of the benzofuropyrimidine skeleton.

12 . The mixed material for the light-emitting element according to claim 4 ,

wherein the first compound further comprises a phenylene group between the benzofuropyrimidine skeleton and the dibenzothiophenyl group, the dibenzofuranyl group, or the carbazolyl group.

13 . The mixed material for the light-emitting element according to claim 2 ,

wherein the first compound further comprises a phenylene group between the benzofuropyrimidine skeleton and the dibenzothiophenyl group, the dibenzofuranyl group, or the carbazolyl group.

14 . The light-emitting device according to claim 3 ,

wherein the first compound further comprises a phenylene group between the benzofuropyrimidine skeleton and the dibenzothiophenyl group, the dibenzofuranyl group, or the carbazolyl group.

15 . The light-emitting device according to claim 3 ,

wherein the light-emitting substance is a fluorescent substance.

16 . The light-emitting device according to claim 3 ,

wherein the light-emitting substance is a phosphorescent substance.

Priority Claims (1)
JP 2013-064261 · Mar 26, 2013 · national
Continuity (6)
Continuation 18116481 · Mar 2, 2023
Continuation 16911892 · Jun 25, 2020
Continuation 16255312 · Jan 23, 2019
Continuation 15890899 · Feb 7, 2018
Continuation 14224641 · Mar 25, 2014
Related Publication 20250048926A1 · Feb 6, 2025
References Cited (127)
US 7312226B2 · Hurley et al. · 2007 [cited by applicant]
US 7326712B2 · Hurley et al. · 2008 [cited by applicant]
US 7326713B2 · Hurley et al. · 2008 [cited by applicant]
US 7335662B2 · Hurley et al. · 2008 [cited by applicant]
US 8007927B2 · Lin et al. · 2011 [cited by applicant]
US 8221905B2 · Lin et al. · 2012 [cited by applicant]
US 8367850B2 · Ma et al. · 2013 [cited by applicant]
US 8415031B2 · Xia et al. · 2013 [cited by applicant]
US 8455111B2 · Ohsawa et al. · 2013 [cited by applicant]
US 8552018B2 · Hurley et al. · 2013 [cited by applicant]
US 8580402B2 · Lin et al. · 2013 [cited by applicant]
US 8586204B2 · Xia et al. · 2013 [cited by applicant]
US 8652652B2 · Brooks et al. · 2014 [cited by applicant]
US 8736157B2 · Seo et al. · 2014 [cited by applicant]
US 8822708B2 · Ma et al. · 2014 [cited by applicant]
US 8866377B2 · Adamovich et al. · 2014 [cited by applicant]
US 8921549B2 · Inoue et al. · 2014 [cited by applicant]
US 8999988B2 · Hurley et al. · 2015 [cited by applicant]
US 9123903B2 · Lin et al. · 2015 [cited by applicant]
US 9123907B2 · Seo et al. · 2015 [cited by applicant]
US 9150551B2 · Suzuki et al. · 2015 [cited by applicant]
US 9153786B2 · Ma et al. · 2015 [cited by applicant]
US 9178158B2 · Kitano et al. · 2015 [cited by applicant]
US 9391283B2 · Ohsawa et al. · 2016 [cited by applicant]
US 9604928B2 · Shitagaki et al. · 2017 [cited by applicant]
US 9905782B2 · Inoue et al. · 2018 [cited by applicant]
US 10193086B2 · Inoue et al. · 2019 [cited by applicant]
US 10573829B2 · Shitagaki et al. · 2020 [cited by applicant]
US 10586934B2 · Shitagaki et al. · 2020 [cited by applicant]
US 10593895B2 · Shitagaki et al. · 2020 [cited by applicant]
US 10700291B2 · Inoue et al. · 2020 [cited by applicant]
US 11600789B2 · Inoue et al. · 2023 [cited by applicant]
US 12069951B2 · Inoue et al. · 2024 [cited by applicant]
US 20060187381A1 · Yokozawa · 2006 [cited by applicant]
US 20080051414A1 · Hurley et al. · 2008 [cited by applicant]
US 20080269239A1 · Harris. et al. · 2008 [cited by applicant]
US 20080314965A1 · Roberts et al. · 2008 [cited by applicant]
US 20090099165A1 · Hurley. et al. · 2009 [cited by applicant]
US 20090143399A1 · Hurley et al. · 2009 [cited by applicant]
US 20090153034A1 · Lin et al. · 2009 [cited by applicant]
US 20090163545A1 · Goldfarb · 2009 [cited by applicant]
US 20100187984A1 · Lin et al. · 2010 [cited by applicant]
US 20110178107A1 · Wang et al. · 2011 [cited by applicant]
US 20120061654A1 · Rayabarapu et al. · 2012 [cited by applicant]
US 20130060037A1 · Lin et al. · 2013 [cited by applicant]
US 20130324721A1 · Inoue et al. · 2013 [cited by applicant]
US 20140042413A1 · Xia et al. · 2014 [cited by applicant]
US 20140103327A1 · Brooks et al. · 2014 [cited by applicant]
US 20150001524A1 · Brooks et al. · 2015 [cited by applicant]
US 20150021555A1 · Kwong et al. · 2015 [cited by applicant]
US 20150372243A1 · Ma et al. · 2015 [cited by applicant]
US 20200194692A1 · Shitagaki et al. · 2020 [cited by applicant]
CN 101878553A · 2010 [cited by applicant]
CN 102341401A · 2012 [cited by applicant]
CN 102449107A · 2012 [cited by applicant]
CN 102690274A · 2012 [cited by applicant]
CN 103137894A · 2013 [cited by applicant]
EP 1776982A · 2007 [cited by applicant]
EP 1829879A · 2007 [cited by applicant]
EP 1860108A · 2007 [cited by applicant]
EP 1860109A · 2007 [cited by applicant]
EP 1678166B · 2009 [cited by applicant]
EP 2511254A · 2012 [cited by applicant]
EP 2703405A · 2014 [cited by applicant]
JP 06220059A · 1994 [cited by applicant]
JP 2007015933A · 2007 [cited by applicant]
JP 2007510627 · 2007 [cited by applicant]
JP 2008519794 · 2008 [cited by applicant]
JP 2011507910 · 2011 [cited by applicant]
JP 2011509247 · 2011 [cited by applicant]
JP 2011084531A · 2011 [cited by applicant]
JP 2012515216 · 2012 [cited by applicant]
JP 2012186461A · 2012 [cited by applicant]
JP 2012522844 · 2012 [cited by applicant]
JP 2012227524A · 2012 [cited by applicant]
JP 2014007397A · 2014 [cited by applicant]
JP 2014192214A · 2014 [cited by applicant]
JP 2014209611A · 2014 [cited by applicant]
JP 6186491 · 2017 [cited by applicant]
KR 20110116177A · 2011 [cited by applicant]
KR 20120026486A · 2012 [cited by applicant]
KR 20120049135A · 2012 [cited by applicant]
WO WO2005037825 · 2005 [cited by applicant]
WO WO2006050965 · 2006 [cited by applicant]
WO WO2007090852 · 2007 [cited by applicant]
WO WO2007090853 · 2007 [cited by applicant]
WO WO2007090854 · 2007 [cited by applicant]
WO WO2009021107 · 2009 [cited by applicant]
WO WO2009021126 · 2009 [cited by applicant]
WO WO2009030981 · 2009 [cited by applicant]
WO WO2009069535 · 2009 [cited by applicant]
WO WO2009081222 · 2009 [cited by applicant]
WO WO2009085344 · 2009 [cited by applicant]
WO WO2009086028 · 2009 [cited by applicant]
WO WO2009086303 · 2009 [cited by applicant]
WO WO2010083359 · 2010 [cited by applicant]
WO WO2010118029 · 2010 [cited by applicant]
WO WO2012102967 · 2012 [cited by applicant]
WO WO2012111579 · 2012 [cited by applicant]
WO WO2012137693 · 2012 [cited by applicant]
WO WO2014065073 · 2014 [cited by applicant]
WO WO2014157599 · 2014 [cited by applicant]
Screen for Chemicals that Extend Yeast Lifespan, https://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=775, 2007, PubChem BioAssay. [cited by applicant]
SMR000047385, https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6603401&loc=ec_rcs, May 25, 2006, PubChem Compound. [cited by applicant]
MLS000039550, https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=663679&loc=ec_rcs, Jun. 29, 2005, PubChem Compound. [cited by applicant]
MLS000558491, https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=9551646&loc=ec_rcs, Oct. 20, 2006, PubChem Compound. [cited by applicant]
International Search Report (Application No. PCT/JP2014/059062) Dated Apr. 22, 2014. [cited by applicant]
Written Opinion (Application No. PCT/JP2014/059062) Dated Apr. 22, 2014. [cited by applicant]
Zhao. Y et al., “Synthesis, X-ray Structure and Antitumor Activity of 4-(1,3,4-thiadiazole-2-ylthio)benzo[4,5]furo[3,2-d]pyrimidine Derivatives”, Chinese Journal of Organic Chemistry, 2010, vol. 30, No. 7, pp. 1093-1097. [cited by applicant]
Goled.S et al., “Synthesis and Reactions of 2-Substituted 4-Hydrazinobenzofuro [3,2-d] Pyrimidines and Their Antibacterial Activity”, Oriental Journal of Chemistry, 1997, vol. 13, No. 1, pp. 73-75. [cited by applicant]
Tolkunov.S et al., “Synthesis and Reactions of 2,4-Disubstituted Benzo[b]Furano, Benzo[b]Thieno and Indolo[3,2-d]-1,3-Oxazinium Salts”, Chemistry of Heterocyclic Compounds, 1990, vol. 26, No. 11, pp. 1310-1312. [cited by applicant]
Chinese Office Action (Application No. 201480018325.0) Dated Oct. 31, 2016. [cited by applicant]
930683-73-1 Registry, STN, Apr. 18, 2007, CAS Registry Record. [cited by applicant]
Mahajan.S et al., “Studies in Benzofurans: Part IX—Synthesis & Reactions of 4-Hydrazinobenzofuro [3,2-d] Pyrimidines”, Indian Journal of Chemistry Section B, Jul. 1, 1980, vol. 19B, No. 7, pp. 596-598. [cited by applicant]
Cramp.S et al., “Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists”, Bioorganic & Medicinal Chemistry Letters, Apr. 15, 2010, vol. 20, No. 8, pp. 2516-2519. [cited by applicant]
Storz.T et al., “Convenient and Practical One-Pot Synthesis of 4-Chloropyrimidines via a Novel Chloroimidate Annulation”, Org. Process Res. Dev. (Organic Process Research & Development), 2011, vol. 15, No. 4, pp. 918-92… [cited by applicant]
CAS Registry No. 1284458-37-2, STN International HCAPLUS database, CAS Registry Record. [cited by applicant]
CAS Registry No. 1284135-04-1, STN International HCAPLUS database, CAS Registry Record. [cited by applicant]
Olah.G et al., “Antimony(V) Chloride”, Encyclopedia of Reagents for organic Synthesis, Apr. 15, 2001, pp. 1-3. [cited by applicant]
Basawaraj.R et al., “Synthesis, antimicrobial and antitubercular activies of some new benzofuro [3,2-d] pyrimidine derivatives”, Indian Journal of Heterocyclic Chemistry, 2012, vol. 22, No. 1, pp. 21-26. [cited by applicant]
Basawaraj.R et al., “Synthesis and biological activities of pyrazolinobenzofuro [3,2-d] pyridimidines”, Indian Journal of Heterocyclic Chemistry, 2011, vol. 21, No. 1, pp. 57-60. [cited by applicant]
Zhao.Y et al., “Synthesis and antitumor activities of heterocycle-substituted benzo [4,5] furo [3,2-d] pyrimidines”, Chinese Journal of Synthetic Chemistry, Dec. 31, 2011, vol. 19, No. 3, pp. 321-324. [cited by applicant]
1148058-92-7/RN, May 21, 2009. [cited by applicant]
328403-18-5/RN, Mar. 22, 2001. [cited by applicant]
Hirota.T et al., “Polycyclic N hetero compounds. XXXIV. Syntheses and evaluation of antidepressive activity of benzofuro [2,3 e]imidazo[1,2 c]pyrimidines and their precursors”, Journal of Heterocyclic Chemistry, 1991, v… [cited by applicant]
Chinese Office Action (Application No. 201810927266.9) Dated Dec. 2, 2020. [cited by applicant]
Chinese Office Action (Application No. 201810927267.3) Dated May 12, 2022. [cited by applicant]